Assessment of Hypoglycemia
A practical guide to recognizing and assessing suspected hypoglycemia, interpreting glucose levels in context, and reassessing patients after initial care.
Recognizing and Interpreting Its Severity
Recognizing and Interpreting Its Severity
can impair brain function, sometimes progressing from confusion or unusual behavior to seizure or coma. Because it may resemble intoxication, stroke, or another neurologic or psychiatric problem, check blood glucose early when assessing altered mental status, seizure, syncope, collapse, or other unexplained illness. Do so even if the person has no known diabetes or lacks typical warning signs.
Two broad symptom patterns
Early autonomic warning signs may include sweating, tremor, palpitations, hunger, anxiety, and pallor. Neuroglycopenic effects occur when the brain receives inadequate glucose and may include headache, dizziness, weakness, difficulty concentrating, confusion, unusual behavior, slurred speech, poor coordination, reduced responsiveness, seizure, or coma. These are possible presentations, not a checklist that every person will show.
Symptoms vary with the person, the rate of glucose decline, and prior episodes. In particular, recurrent or impaired awareness can mean few or no warning signs before substantial cognitive impairment. An atypical presentation—such as apparent intoxication, sudden behavior change, weakness, collapse, or stroke-like signs—therefore still warrants considering .
ADA glucose levels and clinical severity
Level 1: Glucose <70 and ≥54 mg/dL (<3.9 and ≥3.0 mmol/L). This is an alert threshold; symptoms may be absent.
Level 2: Glucose <54 mg/dL (<3.0 mmol/L). This is clinically significant low glucose; may occur.
Level 3: No specific glucose cutoff. This is altered mental or physical function requiring another person’s assistance to recover.
The key distinction is that Level 3 is classified by clinical effects and the need for assistance, not by a particular meter reading. A glucose value alone does not establish whether a person meets that definition. Follow local EMS protocols for treatment thresholds and procedures.
A low reading also does not close the diagnostic process: can coexist with trauma, stroke, infection, intoxication, or another emergency. Persistent focal deficits or altered mental status after glucose improves need further evaluation.
Building the Assessment: History, Glucose, and Neurologic Findings
Building the Assessment: History, Glucose, and Neurologic Findings
A helps connect the presentation to possible risks or causes. Ask the patient, family, caregivers, or bystanders about diabetes and prior episodes—especially severe events or reduced awareness of warning symptoms. Clarify the onset and course of symptoms and any recent glucose readings, continuous glucose monitor (CGM) alerts, or treatment already given.
Ask specifically about insulin, sulfonylureas, meglitinides, and other diabetes medicines; the timing and amount of the last dose; and whether an insulin pump or automated insulin-delivery device is present. Also ask about missed, delayed, or unusually small meals; vomiting; recent exercise or changes in routine; alcohol or possible medication or substance ingestion; and kidney or liver disease, serious illness, frailty, cognitive impairment, or difficulty managing food and medicines safely. Prior significant matters because it increases the likelihood of another event. Do not require a known diabetes history before assessing a compatible presentation.
Structure the initial assessment
Address immediate threats. Use an ABC approach: assess airway protection, breathing, circulation, responsiveness, and injury risk. Manage urgent threats under the applicable protocols.
Check glucose promptly. Obtain a point-of-care measurement when practical, without delaying urgent stabilization. Interpret a low reading alongside the clinical picture rather than treating one result as the entire assessment.
Assess neurologic status. Record mental status and an appropriate standardized level-of-consciousness score. Check for focal deficits, speech changes, coordination problems, and seizure activity. A low glucose does not rule out stroke or another neurologic emergency; reassess persistent or focal findings.
Look for clues and complications. Note signs such as sweating, tremor, pallor, or dehydration, and look for a tongue bite, evidence of a fall, medical identification, or a diabetes device. Obtain relevant vital signs and consider alternate or concurrent causes.
Use witness accounts. Confusion, seizure, or reduced consciousness may make the patient’s account unreliable. Ask witnesses what happened before the event and what treatment was given.
When a reading and presentation disagree
If the glucose result conflicts with the presentation, check the measurement technique and sample site, then repeat according to device instructions and local protocol. During rapid glucose change, a CGM reading may not match blood glucose. Use a point-of-care measurement when available and clinically appropriate. Continue evaluating other causes even when a low result is confirmed.
When Seizure Is the First Sign
When Seizure Is the First Sign
A seizure may be the first obvious sign of severe , so a person’s presentation—not the presence of earlier warning symptoms—should guide concern. Treat the seizure as time-critical: protect the patient from injury and support airway and breathing under the applicable seizure and airway protocols.
Check glucose as soon as feasible, but do not let the measurement delay time-critical seizure care. After the seizure, reassess mental status and glucose. Confusion at that point may be postictal, reflect persistent , or involve both; the assessment should not assume one explanation without checking.
A -associated seizure requires transport for further evaluation under EMS treat-and-release guidance. Continue to consider other causes, particularly if altered mental status or focal neurologic findings persist after glucose improves.
Reassessment, Recurrence, and Further Evaluation
Reassessment, Recurrence, and Further Evaluation
Apparent improvement after initial treatment does not complete the assessment. According to local protocol, recheck glucose and reassess mental status, symptoms, airway protection, vital signs, and neurologic findings. Confirm that improvement is sustained. If oral intake is being considered, confirm that the patient can safely take and retain food or drink.
Document glucose values and times, symptoms, treatment, and the response. This record helps make the course of the event and the response to care clear.
Watch for persistent or recurrent low glucose
may persist or recur if its cause remains active—for example, after insulin or longer-acting glucose-lowering medicines—or if the patient cannot eat. If symptoms persist, return, or do not match the glucose result, repeat the glucose check as indicated and consider other causes of illness. Do not treat an initial improvement as proof that the risk has passed.
Repeated or severe episodes, seizure, injury, inability to protect the airway, significant comorbidity, or an uncertain cause generally call for further evaluation. Persistent focal deficits or altered mental status after glucose improves also need further evaluation rather than attribution to alone. Follow local transport and disposition rules.
: Warning signs associated with the body’s autonomic response to low glucose.
: A glucose measurement obtained at the point of care using an appropriate device.